Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mo Chen, Jian-Pei Fang, Chuan-Xin Zhou, Xin-Yu Li, Shao-Fen Lin & Lu-Hong Xu. (2021) Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia. Hematology 26:1, pages 31-36.
Read now
Read now
Derek Weycker, Ahuva Hanau, Mark Hatfield, Hongsheng Wu, Anjali Sharma, Mark E. Bensink, David Chandler, Aaron Grossman & Michael Tarantino. (2020) Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. Journal of Medical Economics 23:2, pages 184-192.
Read now
Read now
Anne Gulbech Ording, Nickolaj Risbo Kristensen, Henrik Frederiksen, Naufil Alam, Shahram Bahmanyar, Waleed Ghanima, Mette Nørgaard & Christian Fynbo Christiansen. (2019) Routine clinical care for chronic immune thrombocytopenia purpura in Denmark, 2009–2015. Hematology 24:1, pages 732-736.
Read now
Read now
Roland E. Kontermann. (2016) Half-life extended biotherapeutics. Expert Opinion on Biological Therapy 16:7, pages 903-915.
Read now
Read now
Articles from other publishers (4)
Marcel Reiser, Klaus M. Josten, Hermann Dietzfelbinger, Anouchka Seesaghur, Markus Schill, Jane Hippenmeyer & Manfred Welslau. (2022) Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany. Acta Haematologica 145:4, pages 394-403.
Crossref
Crossref
Inderjeet Singh, R. K. Swetha, Ronak Patel, Meghana Dahiya, Vinu Jose, Ankit Patel, Miteshkumar Halvawala, Avinash Kumar Singh, Tuphan Dolai, Eva Bhagat, Rahul Bhargava, Sanjukta S. Rao, Sameer Melinkeri, Maitreyee Bhattacharya, Vikram Mathews & Jose M. Easow. (2021) Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of a Romiplostim Biosimilar in Chronic Refractory Immune Thrombocytopenic Purpura (ITP) Patients. Indian Journal of Hematology and Blood Transfusion 38:1, pages 111-121.
Crossref
Crossref
Jasjit Kaur Rooprai & Karima Khamisa. (2018) Is There a Role for Biweekly Romiplostim in the Management of Chronic Immune Thrombocytopenia (ITP)? A Report of Three Cases. Case Reports in Hematology 2018, pages 1-6.
Crossref
Crossref
Romain Gellens, Sabrina Habchi, Sebastien Freppel, David Couret & Silvia Iacobelli. (2018) Romiplostim for the Emergency Management of Severe Immune Thrombocytopenia with Intracerebral Hemorrhage. Frontiers in Neurology 8.
Crossref
Crossref